Key points are not available for this paper at this time.
We recommend screening for elevated Lp(a) in those at intermediate or high CVD/CHD risk, a desirable level <50 mg/dL as a function of global cardiovascular risk, and use of niacin for Lp(a) and CVD/CHD risk reduction.
Building similarity graph...
Analyzing shared references across papers
Loading...
Børge G. Nordestgaard
M. John Chapman
Kausik K. Ray
European Heart Journal
Columbia University
Inserm
New York University
Building similarity graph...
Analyzing shared references across papers
Loading...
Nordestgaard et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d56dd375589c71d767d0ff — DOI: https://doi.org/10.1093/eurheartj/ehq386